Dihydroxy Etravirine | CAS 1246818-67-6 - Request Quote
Dihydroxy Etravirine
| SZ CAT No: | SZ-E038008 |
| CAS No | 1246818-67-6 |
| Mol.F. | C20H15BrN6O3 |
| Mol.Wt. | 467.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dihydroxy Etravirine is chemically 4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-bis(hydroxymethyl)benzonitrile. Dihydroxy Etravirine is supplied with detailed characterization data compliant with regulatory guideline. Dihydroxy Etravirine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Etravirine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1246818-67-6
Purchase 1246818-67-6
Order 1246818-67-6
Enquire 1246818-67-6
price of 1246818-67-6
1246818-67-6 Supplier
1246818-67-6 Manufacturer
1246818-67-6 Exporter
buy high quality Dihydroxy Etravirine
Purchase Dihydroxy Etravirine
Dihydroxy Etravirine suppliers
Dihydroxy Etravirine manufacturers
Dihydroxy Etravirine price
Order Dihydroxy Etravirine
Enquire Dihydroxy Etravirine
Dihydroxy Etravirine cost
Dihydroxy Etravirine Supplier
Dihydroxy Etravirine Distributor
Dihydroxy Etravirine for Method Validation
Etravirine Reference Standard
Dihydroxy Etravirine for ANDA Filing
Dihydroxy Etravirine for Forced Degradation Studies
Dihydroxy Etravirine Identification Standards
Dihydroxy Etravirine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.